Feynman Point Asset Management LLC Cuts Stake in Core Scientific, Inc. $CORZ

Feynman Point Asset Management LLC lessened its stake in Core Scientific, Inc. (NASDAQ:CORZ) by 47.6% in the 1st quarter, Holdings Channel reports. The institutional investor owned 109,336 shares of the company’s stock after selling 99,129 shares during the quarter. Core Scientific accounts for 2.0% of Feynman Point Asset Management LLC’s holdings, making the stock its 7th biggest position. Feynman Point Asset Management LLC’s holdings in Core Scientific were worth $1,636,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Situational Awareness LP raised its holdings in shares of Core Scientific by 42.5% during the fourth quarter. Situational Awareness LP now owns 28,756,478 shares of the company’s stock worth $418,694,000 after acquiring an additional 8,575,944 shares during the period. Value Aligned Research Advisors LLC acquired a new position in Core Scientific in the 4th quarter worth $117,786,000. Vanguard Group Inc. boosted its stake in Core Scientific by 18.7% in the 4th quarter. Vanguard Group Inc. now owns 33,960,320 shares of the company’s stock worth $494,462,000 after purchasing an additional 5,359,710 shares during the period. Fifth Third Bancorp bought a new position in Core Scientific during the 1st quarter worth about $59,802,000. Finally, Clearline Capital LP increased its holdings in Core Scientific by 274.2% during the 4th quarter. Clearline Capital LP now owns 4,689,443 shares of the company’s stock worth $68,278,000 after purchasing an additional 3,436,127 shares in the last quarter.

Analyst Ratings Changes

A number of brokerages have recently commented on CORZ. Jefferies Financial Group boosted their price target on Core Scientific from $24.00 to $37.00 and gave the company a “buy” rating in a report on Thursday, May 14th. Freedom Capital upgraded Core Scientific to a “hold” rating in a report on Monday, June 15th. Needham & Company LLC reissued a “buy” rating and issued a $29.00 target price on shares of Core Scientific in a research report on Tuesday. Lucid Cap Mkts raised Core Scientific to a “strong-buy” rating in a research report on Friday, June 12th. Finally, Canaccord Genuity Group set a $30.00 target price on Core Scientific in a research note on Friday, May 8th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $30.39.

Core Scientific Stock Performance

Shares of NASDAQ CORZ opened at $20.75 on Wednesday. The stock has a 50 day moving average price of $25.32 and a 200 day moving average price of $20.77. Core Scientific, Inc. has a 52 week low of $12.60 and a 52 week high of $30.46. The stock has a market capitalization of $6.60 billion, a PE ratio of -18.20 and a beta of 5.50.

Core Scientific (NASDAQ:CORZ) last posted its quarterly earnings results on Tuesday, July 28th. The company reported ($3.32) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.06) by ($3.26). The business had revenue of $164.20 million during the quarter, compared to analysts’ expectations of $144.83 million. As a group, research analysts forecast that Core Scientific, Inc. will post 0.08 EPS for the current year.

Key Stories Impacting Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: AMD partnership creates significant long-term revenue potential. AMD will secure up to 2.5 gigawatts of Core Scientific data-center capacity for AI deployments. The initial 530-megawatt rollout across five sites is backed by 15-year agreements and could generate approximately $14 billion in potential base contracted revenue. AMD also received warrants to purchase 30 million CORZ shares at $23.47, with vesting tied to successful capacity deployment. Reuters AMD infrastructure partnership article
• Positive Sentiment: Colocation growth reinforces the AI pivot. Second-quarter revenue reached $164.2 million, while colocation revenue reportedly climbed to $136.7 million from $10.6 million a year earlier. The company said adjusted EBITDA was $41.1 million, suggesting improving operating performance despite reported accounting losses. Core Scientific second-quarter results
• Positive Sentiment: Analyst support and bullish options activity added momentum. Needham reaffirmed a Buy rating with a $29 price target, while BTIG maintained Buy with a $38 target. Call-option volume was approximately 55% above its average daily level, indicating increased speculative interest, though options activity is not a guarantee of future gains.
• Neutral Sentiment: Reported earnings contained conflicting signals. Core Scientific posted a $3.32-per-share quarterly GAAP loss, far below consensus, but another earnings measure cited by Zacks showed adjusted EPS of $0.18 versus expectations for a $0.02 loss. The GAAP deficit was reportedly driven largely by noncash warrant fair-value adjustments.
• Negative Sentiment: Execution, dilution and spending risks remain material. Core Scientific incurred approximately $797.5 million in quarterly capital expenditures to convert mining sites for high-density computing. The AMD warrants could dilute shareholders, while an insider’s sale of 10,000 shares and a recent KBW downgrade to Market Perform may temper enthusiasm.

Insider Activity at Core Scientific

In other news, insider Todd M. Duchene sold 10,000 shares of the stock in a transaction that occurred on Monday, July 20th. The stock was sold at an average price of $22.30, for a total value of $223,000.00. Following the completion of the sale, the insider owned 1,999,101 shares of the company’s stock, valued at approximately $44,579,952.30. This represents a 0.50% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Over the last three months, insiders sold 80,000 shares of company stock valued at $2,025,400. Corporate insiders own 1.70% of the company’s stock.

Core Scientific Company Profile

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.